Title:
ANTI-SIGLEC15 ANTIBODIES AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/241538
Kind Code:
A1
Abstract:
This disclosure provides an anti-SIGLEC15 antibody, antigen-binding fragment, and the use thereof.
Inventors:
YANG YONGFEI (CN)
YAO FENGPING (CN)
SONG PAN (CN)
QU AIDONG (CN)
LI XIULING (CN)
LIANG HONGYUAN (CN)
YAO FENGPING (CN)
SONG PAN (CN)
QU AIDONG (CN)
LI XIULING (CN)
LIANG HONGYUAN (CN)
Application Number:
PCT/CN2023/099828
Publication Date:
December 21, 2023
Filing Date:
June 13, 2023
Export Citation:
Assignee:
BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD (CN)
SHANGHAI INST OF BIOLOGICAL PRODUCTS CO LTD (CN)
SHANGHAI INST OF BIOLOGICAL PRODUCTS CO LTD (CN)
International Classes:
C07K16/46; A61K39/395; A61P35/00; C12N5/00; C12N15/13; C12N15/63
Domestic Patent References:
| WO2015192214A1 | 2015-12-23 | |||
| WO2021190622A1 | 2021-09-30 | |||
| WO2021254132A1 | 2021-12-23 |
Foreign References:
| CA2868959A1 | 2013-10-03 | |||
| CA3033571A1 | 2018-03-29 | |||
| CN112694532A | 2021-04-23 | |||
| CN113801230A | 2021-12-17 | |||
| CN113817057A | 2021-12-21 |
Attorney, Agent or Firm:
BEIJING LINKTEC IP LAW FIRM (SPECIAL GENERAL PARTNERSHIP) (CN)
Download PDF: